$Intellia _老虎社区_美港股上老虎

CUBBE
2019-03-02

$Intellia Therapeutics Inc(NTLA)$从发现遗传物质的双螺旋结构至今，当人类对于自身的认知上升到这个层面，求知欲和时不我待的发展前景引诱着数以万计的科学工作者投身其中……人，得以在并不清楚何为人的前提下，首先改造人，这是何等的恐怖，却又是何等的使人欣喜。倘若当真物竞天择，失败的路线不过是一个方向的消亡，而多样性和迭代速度不才是进化的关键，更多的报备和观察，更多的制约和自律，更多的问题和方法，没有什么道路是一帆风顺的，而这一切的发展，如果说一定有一个开端，即是眼前，便是如下，Editas Medicine, Intellia Therapeutics Inc, Crispr Therapeutics.

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

石家庄二炮手
·2019-03-04
有点高深
回复
点赞
举报

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":414255,"tweetId":"414255","gmtCreate":1551534622381,"gmtModify":1704791232606,"author":{"id":309487271075094,"idStr":"309487271075094","authorId":309487271075094,"authorIdStr":"309487271075094","name":"CUBBE","avatar":"https://static.laohu8.com/b75907dfc79f99d11b9672fe5d3cea68","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$Intellia Therapeutics Inc(NTLA)$从发现遗传物质的双螺旋结构至今，当人类对于自身的认知上升到这个层面，求知欲和时不我待的发展前景引诱着数以万计的科学工作者投身其中……人，得以在并不清楚何为人的前提下，首先改造人，这是何等的恐怖，却又是何等的使人欣喜。倘若当真物竞天择，失败的路线不过是一个方向的消亡，而多样性和迭代速度不才是进化的关键，更多的报备和观察，更多的制约和自律，更多的问题和方法，没有什么道路是一帆风顺的，而这一切的发展，如果说一定有一个开端，即是眼前，便是如下，Editas Medicine, Intellia Therapeutics Inc, Crispr Therapeutics.</p></body></html>","htmlText":"<html><head></head><body><p>$Intellia Therapeutics Inc(NTLA)$从发现遗传物质的双螺旋结构至今，当人类对于自身的认知上升到这个层面，求知欲和时不我待的发展前景引诱着数以万计的科学工作者投身其中……人，得以在并不清楚何为人的前提下，首先改造人，这是何等的恐怖，却又是何等的使人欣喜。倘若当真物竞天择，失败的路线不过是一个方向的消亡，而多样性和迭代速度不才是进化的关键，更多的报备和观察，更多的制约和自律，更多的问题和方法，没有什么道路是一帆风顺的，而这一切的发展，如果说一定有一个开端，即是眼前，便是如下，Editas Medicine, Intellia Therapeutics Inc, Crispr Therapeutics.</p></body></html>","text":"$Intellia Therapeutics Inc(NTLA)$从发现遗传物质的双螺旋结构至今，当人类对于自身的认知上升到这个层面，求知欲和时不我待的发展前景引诱着数以万计的科学工作者投身其中……人，得以在并不清楚何为人的前提下，首先改造人，这是何等的恐怖，却又是何等的使人欣喜。倘若当真物竞天择，失败的路线不过是一个方向的消亡，而多样性和迭代速度不才是进化的关键，更多的报备和观察，更多的制约和自律，更多的问题和方法，没有什么道路是一帆风顺的，而这一切的发展，如果说一定有一个开端，即是眼前，便是如下，Editas Medicine, Intellia Therapeutics Inc, Crispr Therapeutics.","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/414255","repostId":0,"isVote":1,"tweetType":1,"viewCount":2596,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NTLA"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":509,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":1362651,"commentId":"1362651","gmtCreate":1551661585883,"gmtModify":1551661585883,"authorId":3462835651625771,"author":{"id":3462835651625771,"idStr":"3462835651625771","authorId":3462835651625771,"name":"石家庄二炮手","avatar":"https://static.tigerbbs.com/eabd15fbc0d913fbb0dc109429347b55","vip":1,"currentWearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":414255,"objectIdStr":"414255","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"有点高深","text":"有点高深","html":"有点高深","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

评论（1）

热议股票